Our data indicate that small molecule inhibitors of VEGF pathway suppress growth of adenocarcinoma lesions in a NSCLC model of KrasG12D-LSL GEMM by targeting components of tumor vasculature and stroma. Here, VEGFA is linked to non-small cell lung carcinoma.